| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/12/2008 | US7329526 Serine proteases from-gram-positive microorganisms |
| 02/12/2008 | US7329525 Bacillus serine proteases for use as active agent in cleaning compounds and detergents |
| 02/12/2008 | US7329524 for efficiently producing heat resistant agaro-oligosaccharide and extracting a nucleic acid from an agarose gel; kits |
| 02/12/2008 | US7329523 Microbiologic industry, such as breeding, L-serine production |
| 02/12/2008 | US7329522 Polyphosphate:AMP phosphotransferase |
| 02/12/2008 | US7329521 Transglutaminase-producing strain |
| 02/12/2008 | US7329520 Reacting the peptide or protein with an enzyme that is extracted from a plant of the genus Zingiber and exhibits defructosylation action |
| 02/12/2008 | US7329519 DNA encoding the cytochrome C, glucose sensor using an enzyme electrode, biosensors |
| 02/12/2008 | US7329518 Producing polycyclic pyridineethanol derivative by causing an enzyme or enzyme source to act on polycyclic acetylpyridine derivatives |
| 02/12/2008 | US7329517 Escapin protein, a broadly antimicrobial compound from ink of the sea hare Aplysia californica, and uses thereof |
| 02/12/2008 | US7329516 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 02/12/2008 | US7329511 Nucleic acid encoding GAD65 |
| 02/12/2008 | US7329497 diagnosing by detecting mutations in the DNA encoding RecQ4 helicase, the causitive gene |
| 02/12/2008 | US7329494 Method of detection and quantification of cGMP by using a cGMP-visualizing probe |
| 02/12/2008 | US7329492 Methods for real-time single molecule sequence determination |
| 02/12/2008 | CA2440025C Aminoketone asymmetric reductase and nucleic acid thereof |
| 02/12/2008 | CA2352609C Expression of alkaline phosphatase in yeast |
| 02/12/2008 | CA2203246C Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 02/12/2008 | CA2190802C A method of preparing and recovering proteins |
| 02/12/2008 | CA2174236C Superoxide dismutase and mimetics thereof |
| 02/12/2008 | CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics |
| 02/07/2008 | WO2008017066A2 Phytases with improved thermal stability |
| 02/07/2008 | WO2008016629A2 Novel glutamic acid decarboxylase (gad) proteins and methods of use |
| 02/07/2008 | WO2008015861A1 Method for designing mutated enzyme, method for preparing the same and mutated enzyme |
| 02/07/2008 | WO2008014574A1 Cleavage of bip by subtilase cytotoxin |
| 02/07/2008 | WO2007138455A3 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2 |
| 02/07/2008 | WO2007138261A3 Modified sugar nucleotide |
| 02/07/2008 | WO2007138043A3 Sirna kinase and methods of use |
| 02/07/2008 | WO2007112005A3 Pc5 as a factor ix propeptide processing enzyme |
| 02/07/2008 | WO2007052326B1 Method for conversion of uric acid to allantoin and related enzymes |
| 02/07/2008 | US20080034456 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 02/07/2008 | US20080034455 Production Of A Protein Localized To The Endoplasmic Reticulum Protein Bodies In A Transgenic Plant And Seed |
| 02/07/2008 | US20080034452 Method for increasing resistance of monocot plants against abiotic stresses, tps plant gene constructs, and transformants |
| 02/07/2008 | US20080034445 comprising a reporter polynucleotide that comprises a GAL4, promoter sequences, activator fusion protein ; anticancer, antiosteoporosis, gene therapy and hormone replacement treatments |
| 02/07/2008 | US20080033151 Therapeutic bioactive ribonucleases for use in the tissue targeted therapy against tumors; tumor cytotoxic factors; antitumor agents |
| 02/07/2008 | US20080033024 Aryl amino acid derivatives as inhibitors for treating inflammation |
| 02/07/2008 | US20080033013 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation |
| 02/07/2008 | US20080032963 Aminopyrimidines useful as kinase inhibitors |
| 02/07/2008 | US20080032945 2'-modified oligonucleotides |
| 02/07/2008 | US20080032378 have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or high-glucose syrup or a mixed syrup, and for liquifying a starch-comprising composition |
| 02/07/2008 | US20080032377 Uracil-DNA nuclease: protein enzyme possessing nuclease activity specific for uracil containing nucleic acid, process for its preparation and methods of use |
| 02/07/2008 | US20080032376 Method for Preparing An Enzyme Containing Granule |
| 02/07/2008 | US20080032374 Method for the Preparation of Lysine by Fermentation of Corynebacterium Glutamicum |
| 02/07/2008 | US20080032369 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms ; plants and microorganisms that produce lipids |
| 02/07/2008 | US20080032368 Pufa polyketide synthase systems and uses thereof |
| 02/07/2008 | US20080032367 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms; plants and microorganisms that produce lipids |
| 02/07/2008 | US20080032351 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
| 02/07/2008 | US20080032350 Alpha-isomaltosylglucosaccharide-forming enzyme, process and uses of the same |
| 02/07/2008 | US20080032338 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
| 02/07/2008 | US20080032337 Genetic engineering; analyze the corresponding expression products, elucidate the pathology of diseases associated with the genes, for example hereditary diseases and cancer, and diagnose and treat such diseases |
| 02/07/2008 | US20080032332 Wound healing agents; anticancer agents; cardiovascular disorders |
| 02/07/2008 | US20080032322 Method for incorporation of two oxygen atoms into digested peptides using peptidases |
| 02/07/2008 | US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor |
| 02/07/2008 | US20080032296 Sequences with FabA-like beta -hydroxyacyl-ACP dehydrase (DH) activity; biosynthesis of polyunsaturated fatty acids (PUFAs) |
| 02/07/2008 | US20080032024 Maltogenic Alpha-Amylase Variants |
| 02/07/2008 | US20080031888 Tumor antigens |
| 02/07/2008 | US20080031864 PEG-Urate Oxidase Conjugates and Use Thereof |
| 02/07/2008 | US20080031817 Inhibition Of Superoxide Dismutase By Tetrathiomolybdate: Identification Of New Anti-Angiogenic And Antitumor Agents |
| 02/07/2008 | CA2659778A1 Cleavage of bip by subtilase cytotoxin |
| 02/06/2008 | EP1884771A1 Protein-immobilized membrane, method for immobilization of protein, enzyme-immobilized electrode, and biosensor |
| 02/06/2008 | EP1884567A1 Nucleic acid molecules encoding a bacterial protein having deacetylase activity, such protein, methods for producing same, and uses thereof |
| 02/06/2008 | EP1884565A1 Novel microorganism, lipid improving agent, and method of producing 2-acyl-lysophospholipid |
| 02/06/2008 | EP1883697A2 Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors |
| 02/06/2008 | EP1883696A1 Serine proteases with altered sensitivity to activity-modulating substances |
| 02/06/2008 | EP1651770B1 Promoter molecules for use in plants |
| 02/06/2008 | EP1402036B1 Expression vectors encoding bacteriophage signal peptides |
| 02/06/2008 | CN101120091A Nucleic acid molecules encoding fatty acid desaturase genes from plants and methods of use |
| 02/06/2008 | CN101117644A Diagnostics and therapeutics for glaucoma |
| 02/06/2008 | CN101117631A Method for manufacturing natto kinase |
| 02/06/2008 | CN101117630A Preparation method of nattokinase powder and natto Brazil mushroom capsule |
| 02/06/2008 | CN101117629A Amylase variants |
| 02/06/2008 | CN101117628A Method for producing phytase |
| 02/06/2008 | CN101117623A Refractory metal prolease gene engineering bacterium and acquiring method therefor |
| 02/06/2008 | CN100366746C Novel alkaline protease from bacillius sp. (DSM 14390) and washing and cleaning products comprising said novel alkaline protease |
| 02/06/2008 | CN100366737C Production of curing lactase |
| 02/06/2008 | CN100366736C Phytase variants |
| 02/06/2008 | CN100366730C Promoter and plasmid system for genetic engineering |
| 02/06/2008 | CN100366293C Inhibitors of complement activation |
| 02/05/2008 | US7326828 Construction of a recombinant DNA construct encoding the phospholipid, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the phospholipid |
| 02/05/2008 | US7326782 Nucleotide sequences coding functional fragment of viomycin gene cluster for use in treatment of tuberculosis |
| 02/05/2008 | US7326781 Polynucleotides encoding the human citron kinase polypeptide, BMSNKC—0020/0021 |
| 02/05/2008 | US7326773 PRO6493 antibodies |
| 02/05/2008 | US7326770 H. pylori fucosyltransferases |
| 02/05/2008 | US7326768 Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 02/05/2008 | US7326681 Methods for producing modified glycoproteins |
| 02/05/2008 | US7326554 Phytase variants |
| 02/05/2008 | US7326553 Maltose-1-phosphate-producing enzyme |
| 02/05/2008 | US7326552 Wild-type kinase domain of human Ephrin receptor A2 (EPHA2) and crystallization thereof |
| 02/05/2008 | US7326551 Nucleotide sequences coding polypeptide for use in generation of bacteria which generate synthetic fuels |
| 02/05/2008 | US7326550 Transformed with a copy of gene coding for lactate dehydrogenase functionally linked to a promoter sequence allowing the expression of the gene; strain has undergone deletion of one to four pyruvate decarboxylase genes or one pyruvate dehydrogenase gene; produces 0.052-0.757 g lactic acid per g glucose |
| 02/05/2008 | US7326549 Myo-inositol oxygenases |
| 02/05/2008 | US7326548 starch conversion for producing fermentation products, such as ethanol, and syrups, such as glucose; fusion polypeptide; mixture with alpha-amylase |
| 02/05/2008 | US7326547 Irradiated plant mutant which generates seed oil with reduced concentrations of polyunsaturated fatty acids |
| 02/05/2008 | US7326546 Culturing Bacillus bacterium that has been modified to increase glucose-6-phosphate dehydrogenase activity to produce nucleoside: inosine, xanthosine, guanosine, or adenosine; phosphorylation to form nucleotide by reacting with a microorganism and phosphoric acid, phenyl phosphate, or carbamyl phosphate |
| 02/05/2008 | US7326541 Fragments and variants of Staphylococcus aureus DNAG primase, and uses thereof |
| 02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
| 02/05/2008 | US7326534 Detection of gleevec resistant mutations |
| 02/05/2008 | US7326531 Proteases from gram-positive organisms |
| 02/05/2008 | US7326530 Method for localizing polypeptide on cell surface |
| 02/05/2008 | US7326419 Membrane proteins or polypeptides, used as vaccines or for medical diagnosis |